China's Biopharma Industry Breaks Away From U.S., Korea And Japan In Development
This article was originally published in PharmAsia News
Executive Summary
China's biopharmaceutical industry has grown 27 percent annually over the past three years, outperforming Germany last year to become the world's fourth-largest pharmaceutical market, a Korean paper reported